Neurilemmoma of the Nasal Cavity and Paranasal Sinuses.

Abstract

OBJECTIVES:

Neurilemmoma in the nasal cavity and paranasal sinuses is very rare. The study aimed to improve the understanding of neurilemmoma in the nasal cavity and paranasal sinuses.

MATERIALS AND METHODS:

The clinical data of 10 patients with neurilemmoma in the nasal cavity and paranasal sinuses treated from January 2014 to June 2019 in our hospital were retrospectively studied.

RESULTS:

There were 6 females and 4 males patients in our study. The mean age was 49.5 years (range 37-77 years), and the most common clinical symptom was unilateral nasal obstruction. The site of tumor included the nasal cavity, maxillary sinus, ethmoid sinus, and sphenoid sinus. There were 2 cases with malignant neurilemmoma. Nine patients underwent functional endoscopic sinus surgery (FESS); however, 1 patient underwent FESS combined with the lateral rhinotomy for complete resection of the tumor. Two patients with malignant neurilemmoma received postoperative radiotherapy. The mean follow-up was 3.82 years (range 2-7 years). There were no incidences of tumor recurrence during the study period.

CONCLUSIONS:

Neurilemmoma in the nasal cavity and paranasal sinuses is a mainly benign tumor. Complete surgical excision by FESS is the only treatment option for neurilemmoma in the nasal cavity and paranasal sinuses; while malignant neurilemmoma needs postoperative radiotherapy.

• Authors: Xindi He, Ying Wang
• Journal: Ear, nose, & throat journal (Ear Nose Throat J) Vol. 102 Issue 7 Pg. NP364-NP368 (Jul 2023) ISSN: 1942-7522 [Electronic] United States
• PMID: 33951978 (Publication Type: Journal Article)

Topics

• Male
• Female
• Humans
• Adult
• Middle Aged
• Aged
• Nasal Cavity (surgery, pathology)
• Paranasal Sinus Neoplasms (pathology)
• Nose Neoplasms (pathology)
• Retrospective Studies
• Neurofibrosarcoma (pathology)
• Neoplasm Recurrence, Local (pathology)
• Paranasal Sinuses (surgery, pathology)
• Neurilemmoma (surgery, pathology)